Asia Pacific Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Design (Single Chamber and Multi-cham

Asia Pacific Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Design (Single Chamber and Multi-chamber), Application (Cancer, Diabetes, Autoimmune Disease, Infectious diseases, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel)

The Asia Pacific prefilled syringe market was valued at US$ 1,225.22 million in 2022 and is expected to reach US$ 2,820.57 million by 2030; it is estimated to register a CAGR of 11.0% from 2022 to 2030.

Strategic Initiatives by Market Players Fuel Asia Pacific Prefilled Syringe Market

Various market players focus on product launches or strategic collaborations for the development of advanced products that help in the treatment of chronic disorders with ease. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:

In April 2023, Delta Med Group partnered with DBM, a leading manufacturer of prefilled syringes. Delta Med Group and DBM will expand their portfolio, profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity. In June 2022, WuXi Biologics launched a drug product facility in China for prefilled syringes. The new facility has PFS capacity of 17 million units per year. The maximum filling speed can reach 400 PFSmin to support the manufacturing of 17 million syringes of drug products every year. In January 2022, Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd., received approval for UniSafe 1 ml safety device for prefilled syringes as a combination product in Asia. In March 2021, SK bioscience launched a new shingles vaccine called ´SKYZoster® Ini.' The newly introduced prefilled syringe type SKYZoster can be administered more conveniently than the current intramuscular injection type in which water for injection and freeze-dried vaccine are mixed and then transferred back into the syringe. Thus, a surge in product launches and strategic collaborations is likely to create considerable growth opportunities for the prefilled syringes market in the future.

Asia Pacific Prefilled Syringe Market Overview

The Asia Pacific prefilled syringes market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2022, and India is expected to have a significant growth rate in the market during 2022-2030. The market growth in these countries is attributed to the advancements in treatment of diabetes that have resulted in rising injectable therapies. Moreover, Chinese Diabetes Society has taken a lead in insulin injection education over the past decade for the treatment of diabetes. Therefore, with high awareness and usability of prefilled syringes intended for diabetes population in China, the market for prefilled syringes will grow subsequently in the near future.

Asia Pacific Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Prefilled Syringe Market Segmentation

The Asia Pacific prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the Asia Pacific prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Asia Pacific prefilled syringe market share in 2022.

In terms of material, the Asia Pacific prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Asia Pacific prefilled syringe share in 2022.

Based on designs, the Asia Pacific prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Asia Pacific prefilled syringe share in 2022.

In terms of application, the Asia Pacific prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Asia Pacific prefilled syringe share in 2022.

By distribution channel, the Asia Pacific prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Asia Pacific prefilled syringe market share in 2022.

Based on country, the Asia Pacific prefilled syringe market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific prefilled syringe market in 2022.

B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Asia Pacific prefilled syringe market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific prefilled syringes market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific prefilled syringes market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving prefilled syringes market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Please Note: It will take 3-5 business days to complete the report upon order confirmation for delivery of the full report and excel data pack for on demand reports.